BRIEF-Gilead Nears Up To $2 Billion Deal For Autoimmune Biotech Ouro Medicines - FT
Reuters
6 hours ago
BRIEF-Gilead Nears Up To $2 Billion Deal For Autoimmune Biotech Ouro Medicines - FT
March 23 (Reuters) -
GILEAD NEARS UP TO $2BN DEAL FOR AUTOIMMUNE BIOTECH OURO MEDICINES - FT
GILEAD WILL PAY PRIVATELY HELD OURO’S INVESTORS ROUGHLY $1.5BN UPFRONT IN CASH AND AT LEAST EXTRA $500MN IF CERTAIN CLINICAL TRIAL MILESTONES ARE HIT - FT
TALKS BETWEEN GILEAD AND OURO MEDICINES ARE AT AN ADVANCED STAGE AND A DEAL COULD BE ANNOUNCED IN THE COMING DAYS - FT
Source text: https://tinyurl.com/3jye8yjx
Further company coverage: GILD.O
((Reuters.Briefs@thomsonreuters.com;))
At the request of the copyright holder, you need to log in to view this content
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.